ROBUST: Lenalidomide-R-CHOP versus placebo-R-CHOP in previously untreated ABC-type diffuse large B-cell lymphoma

Activated B-cell-like (ABC) diffuse large B-cell lymphoma (DLBCL), the major constituent of nongerminal center B-cell-like (non-GCB) DLBCL, is associated with poorer survival outcomes than GCB-type DLBCL. In Phase II studies, lenalidomide combined with R-CHOP (R(2)-CHOP) improved outcomes relative t...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Future Oncol
Main Authors: Nowakowski, Grzegorz S, Chiappella, Annalisa, Witzig, Thomas E, Spina, Michele, Gascoyne, Randy D, Zhang, Lei, Flament, Jocelyne, Repici, Jacqueline, Vitolo, Umberto
Format: Artigo
Sprog:Inglês
Udgivet: Future Medicine Ltd 2016
Fag:
Clinical Trial Protocol
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5551933/
https://ncbi.nlm.nih.gov/pubmed/27089170
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2217/fon-2016-0130
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker